DURABLE SURFACE COATINGS

Abstract

Described herein are durable coatings, i.e. for medical devices, and methods of forming the coatings.

Claims

1. A coating, comprising a base coat and a top coat covalently linked to the base coat, wherein the base coat includes an alkylsilanyl moiety, and the top coat includes a polymeric moiety having an amine moiety.

2. The coating of claim 1, wherein the coating is covalently linked to a surface.

3. The coating of claim 1, wherein the polymeric moiety is a p(MEA-co-APMA) polymer, an amine functionalized poly(ethylene glycol) polymer, an amine functionalized poly(vinyl alcohol), an amine functionalized hyaluronic acid, an amine functionalized poly(vinyl pyrrolidone), or a combination thereof.

4. The coating of claim 1, wherein the alkylsilanyl moiety is (C.sub.1-20 alkyl)silanyl.

5. The coating of claim 1, wherein the alkylsilanyl moiety is propylsilanyl, propylmethoxysilanyl, propyldimethoxysilanyl, heptylsilanyl, heptylmethoxysilanyl, heptyldimethoxysilanyl, undecylsilanyl, undecylmethoxysilanyl, undecyldimethoxysilanyl, or a combination thereof.

6. The coating of claim 1, wherein the base coat and top coat are covalently linked such that an aminoalkylsilanyl moiety is present.

7. The coating of claim 1, wherein the amine moiety is a secondary amine or a tertiary amine.

8. The coating of claim 1, wherein the coating is about 100 nanometers thick or less.

9. The coating of claim 1, wherein the coating is about 10 nanometers thick or less.

10. The coating of claim 1, wherein the coating is about 1 nanometer thick.

11. A medical device, comprising the coating of claim 1 covalently linked to a surface of the medical device.

12. A process for forming the coating of claim 1, including contacting a haloalkylsilanyl moiety with a hydrophilic polymeric moiety having an amine moiety to form the coating.

13. The process of claim 12, wherein the haloalkylsilanyl moiety is halopropylsilanyl, halopropylmethoxysilanyl, halopropyldimethoxysilanyl, haloheptylsilanyl, haloheptylmethoxysilanyl, haloheptyldimethoxysilanyl, haloundecylsilanyl, haloundecylmethoxysilanyl, haloundecyldimethoxysilanyl, or a combination thereof.

14. The process of claim 13, wherein the halo is bromo.

15. A process for coating a medical device, including: a) contacting a halosilanyl compound with a surface of the medical device to form a base coat; and b) contacting the base coat with a hydrophilic polymeric moiety having an amine moiety to form a top coat, wherein the base coat is covalently linked to the surface of the medical device, and the top coat is covalently linked to the base coat.

16. The process of claim 15, wherein the halosilanyl compound is 3-bromopropyltrimethoxysilane, 7-bromoheptyltrimethoxysilane, 11-bromoundecyltrimethoxysilane, or a combination thereof.

17. The process of claim 15, wherein the process is performed with the surface of the medical device at least partially submerged in a solution.

18. The process of claim 15, further comprising a curing step subsequent to forming the base coat and prior to forming the top coat.

19. The process of claim 15, further comprising contacting the surface of the medical device with a hydroxylating agent prior to forming the base coat.

20. A surface, comprising the coating of claim 1 covalently linked to the surface.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0006] FIG. 1 shows an example of a coating, and a general process for preparing the coating on a surface.

[0007] FIG. 2 shows the average tensile pull force (g) with 900 g Teflon clamp force of a coated nitinol wire compared to a control, as described in Example 1.

DETAILED DESCRIPTION

[0008] Described herein are substrate coatings, i.e. durable surface coatings, and processes for preparing the coatings. In some embodiments, the coatings can be used for medical devices.

Definitions

[0009] Listed below are definitions of various terms used to describe the compositions and methods provided herein. These definitions apply to the terms as they are used throughout this specification and claims, unless otherwise limited in specific instances, either individually or as part of a larger group.

[0010] Unless defined otherwise, all technical and scientific terms used herein generally have the same meaning as commonly understood by one of ordinary skill in the art to which the compositions and methods provided herein pertain. Generally, the nomenclature used herein and the laboratory procedures in cell culture, molecular genetics, organic chemistry, and peptide chemistry are those well-known and commonly employed in the art.

[0011] As used herein, the articles “a” and “an” refer to one or to more than one (i.e. to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element. Furthermore, use of the term “including” as well as other forms, such as “include”, “includes,” and “included,” is not limiting.

[0012] As used herein, the term “about” will be understood by persons of ordinary skill in the art and will vary to some extent on the context in which it is used. As used herein when referring to a measurable value such as an amount, a temporal duration, and the like, the term “about” is meant to encompass variations of ±20% or ±10%, more preferably ±5%, even more preferably ±1%, and still more preferably ±0.1% from the specified value, as such variations are appropriate to perform the disclosed compositions and methods.

Coatings

[0013] Surface coatings are described. Thus, in one aspect described are coatings, comprising a base coat and a top coat covalently linked to the base coat, wherein the base coat includes an alkylsilanyl moiety, and the top coat includes a hydrophilic or amphiphilic polymeric moiety having an amine moiety.

[0014] In some embodiments, the coating is covalently linked to a surface. Thus, provided herein are surfaces, comprising the coatings described herein covalently linked to the surfaces. In some embodiments, the surface is a surface of a medical device. In some embodiments, the medical device is a catheter, a guide wire, a stent, or an access device. Thus, in some embodiments described are medical devices having a portion of its surface, or all of its surfaces, coated with the one or more of the coatings provided herein. In some embodiments, a medical device is described, comprising a coating described herein covalently linked to a surface of the medical device.

[0015] In some embodiments, the polymeric moiety is a p(MEA-co-APMA) polymer, an amine functionalized poly(ethylene glycol) polymer, an amine functionalized poly(vinyl alcohol), an amine functionalized hyaluronic acid, an amine functionalized poly(vinyl pyrrolidone), or a combination thereof.

[0016] In some embodiments, the alkylsilanyl moiety is (C.sub.1-20 alkyl)silanyl.

[0017] In some embodiments, the alkylsilanyl moiety is propylsilanyl, propylmethoxysilanyl, propyldimethoxysilanyl, heptylsilanyl, heptylmethoxysilanyl, heptyldimethoxysilanyl, undecylsilanyl, undecylmethoxysilanyl, undecyldimethoxysilanyl, or a combination thereof.

[0018] In some embodiments, the base coat and top coat are covalently linked such that an aminoalkylsilanyl moiety is present.

[0019] In some embodiments, the amine moiety is a secondary amine or a tertiary amine.

[0020] In some embodiments, the coating is about 100 nanometers thick or less. In some embodiments, the coating is about 10 nanometers thick or less. In some embodiments, the coating is about 1 nanometer thick.

[0021] In some embodiments, the coatings include a structure according to Formula I:

##STR00001##

[0022] wherein

[0023] Z-J is the polymeric moiety described above, and J is the amine of the polymeric moiety;

[0024] R.sup.1 is C.sub.1-20 alkyl;

[0025] R.sup.2 is a substrate;

[0026] R.sup.3 and R.sup.4 are each, independently, C.sub.1-6 alkyl, or each of R.sup.3 and R.sup.4 may be a bond that is covalently linked to R.sup.2.

[0027] In some embodiments, the coatings include a structure according to Formula II:

##STR00002##

[0028] wherein Z-J, R.sup.1, and R.sup.2 are as defined above.

[0029] In some embodiments, the coatings include a structure according to Formula III:

##STR00003##

[0030] wherein Z-J, R.sup.1, and R.sup.2 are as defined above, and R.sup.4 is C.sub.1-6 alkyl.

[0031] In some embodiments, the coatings include a structure according to Formula IV:

##STR00004##

[0032] wherein Z-J, R.sup.1, and R.sup.2 are as defined above, and R.sup.3 and R.sup.4 are each, independently, C.sub.1-6 alkyl.

[0033] In some embodiments, J is a secondary amine. In some embodiments, J is a tertiary amine. In some embodiments, the coatings provided herein include more than one structure of the Formulae provided such that the coatings include J being a secondary amine on one of the Formulae, and J being a tertiary amine on another of the Formulae.

[0034] In some embodiments, the coating includes a combination of the structures selected from Formula II, Formula III, or Formula IV.

[0035] A substrate's material composition can be, for example, any metallic/alloy (including, but not limited to, nitinol, stainless steel, cobalt chromium), any plastic/polymer (including, but not limited to, grilamide, Pbax, PEEK), any glass surfaces, any surface including hydroxyl moieties on the surface, or any surface that can be treated to provide hydroxyl moieties on the surface.

[0036] The substrates can be virtually in any form. In some embodiments, the substrate is an access device. In some embodiments, the substrate is a catheter. In some embodiments, the substrate is a guide wire. In some embodiments, the substrate is formed into an implantable medical device. In some embodiments, the substrate may be in the form of a flat coupon, hypo tube, wire, woven wire, or laser cut object. In some embodiments, the substrate may be formed into a stent such as a braided stent platform.

[0037] One advantage of the coatings provided herein is that they can provide a surface (i.e. of a medical device) having a coating with enhanced durability, enhanced lubricity, or enhanced durability and lubricity.

Coating Processes

[0038] In one embodiment, surface modification of a substrate surface is described. In one embodiment, the substrate surface is a hydroxylated substrate surface.

[0039] One method of surface functionalizing a substrate is through silane chemistry. Haloalkylsilanes represent one possible compound having reactivity suitable for substrate modification. FIG. 1 indicates one suggested pathway that haloalkylsilanes may react with a hydroxylated substrate surface. The covalent linkage of haloalkylsilanes to a hydroxylated substrate can yield linkages having one, two, or three covalent bonds between the haloalkylsilane and the substrate surface. Herein, haloalkysilanes are used as a base coat of the substrate surface to further react biocompatible molecules or polymers as a top coat to a substrate surface, such as a surface of a medical device.

[0040] In some embodiments, a substrate to be coated is treated with a hydroxylating agent to induce the presence of hydroxyl moieties on the surface. Such hydroxylating agents include, but are not limited to, hydrogen peroxide or plasma treatments.

[0041] Once a hydroxylated surface is obtained, a halo-silane (in some embodiments a haloalkylsilane) can be used to activate the surface for amine functional polymer bonding.

[0042] In some embodiments, the haloalkylsilane has a structure according to Formula V:

##STR00005##

[0043] wherein

[0044] X is iodo, chloro, or bromo;

[0045] R.sup.1 is C.sub.1-20 alkyl; and

[0046] each of R.sup.3, R.sup.4, and R.sup.5 are, independently, C.sub.1-6 alkyl.

[0047] In some embodiments, the haloalkylsilane has a structure according to Formula VI:

##STR00006##

[0048] wherein

[0049] X is iodo, chloro, or bromo;

[0050] R.sup.1 is C.sub.1-20 alkyl; and

[0051] each of R.sup.3 and R.sup.5 are, independently, C.sub.1-6 alkyl.

[0052] In some embodiments, the haloalkylsilane has a structure according to Formula VII:

##STR00007##

[0053] wherein

[0054] X is iodo, chloro, or bromo;

[0055] R.sup.1 is C.sub.1-20 alkyl; and

[0056] R.sup.3 is C.sub.1-6 alkyl.

[0057] In some embodiments of these Formulae, X is bromo.

[0058] In some embodiments of the Formulae provided herein, R.sup.1 is C.sub.3-11 alkyl.

[0059] In some embodiments of the Formulae provided herein, each of R.sup.3, R.sup.4, and R.sup.5 are, independently, methyl or ethyl. In some embodiments, each of R.sup.3, R.sup.4, and R.sup.5 are methyl.

[0060] In some embodiments, X is bromo, and R.sup.3 is methyl.

[0061] In some embodiments, the haloalkylsilane is halopropylsilanyl, halopropylmethoxysilanyl, halopropyldimethoxysilanyl, haloheptylsilanyl, haloheptylmethoxysilanyl, haloheptyldimethoxysilanyl, haloundecylsilanyl, haloundecylmethoxysilanyl, haloundecyldimethoxysilanyl, or a combination thereof.

[0062] In some embodiments, halo is iodo, choro, or bromo. In some embodiments, halo is bromo.

[0063] In some embodiments, described herein are processes for forming the coatings described herein, including contacting a haloalkylsilanyl moiety with a polymeric moiety having an amine moiety to form the coating.

[0064] In some embodiments, the polymeric moiety is a hydrophilic polymeric moiety. In some embodiments, the polymeric moiety is an amphiphilic polymeric moiety.

[0065] In some embodiments, the haloalkylsilanyl moiety is halopropylsilanyl, halopropylmethoxysilanyl, halopropyldimethoxysilanyl, haloheptylsilanyl, haloheptylmethoxysilanyl, haloheptyldimethoxysilanyl, haloundecylsilanyl, haloundecylmethoxysilanyl, haloundecyldimethoxysilanyl, or a combination thereof. In some embodiments, the halo is iodo, chloro, or bromo. In some embodiments, the halo is bromo.

[0066] In some embodiments, described herein are processes for coating a medical device, including:

[0067] a) contacting a halosilanyl compound with a surface of the medical device to form a base coat; and

[0068] b) contacting the base coat with a hydrophilic polymeric moiety having an amine moiety to form a top coat,

[0069] wherein the base coat is covalently linked to the surface of the medical device, and the top coat is covalently linked to the base coat.

[0070] In some embodiments of the processes described herein, the halosilanyl compound is 3-bromopropyltrimethoxysilane, 7-bromoheptyltrimethoxysilane, 11-bromoundecyltrimethoxysilane, or a combination thereof.

[0071] In some embodiments, the process is performed with the surface of the medical device at least partially submerged in a solution.

[0072] In some embodiments, the processes further comprise a curing step subsequent to forming the base coat and prior to forming the top coat.

[0073] In some embodiments, the processes further comprise contacting the surface of the medical device with a hydroxylating agent prior to forming the base coat.

[0074] One advantage of the processes provided herein is that a single layer of base coat and top coat can be disposed on the surface, thereby providing a single coating layer on the surface that is on the order of one nanometer thick. By contrast, multiple layers are bonded in traditional guidewire and catheter coating technologies that produce micron thick coatings.

Examples

[0075] The following Examples further illustrate aspects of the compositions and methods provided herein. However, these Examples are in no way a limitation of the teachings or disclosure as set forth herein. These Examples are provided for illustration purposes.

Example 1: Applying a Coating to a Surface

[0076] A coating was applied to electropolished nitinol wires as shown in FIG. 1. The metallic substrate was hydroxylated, covalently functionalized with a bromo-silane, then an amine-functionalized polymer [p(MEA-co-APMA)] (N-(3-aminopropyl)methacrylamide=APMA, and 2-methoxyethyl acrylate=MEA) was covalently attached.

Example 2: Lubricity Assessment

[0077] The coated nitinol wires prepared in Example 1 were tested using an OakRiver durability and lubricity test system. Tests were performed by pulling the coated nitinol wire through Teflon pad grips set at a clamping force of 900 g. Initial data, shown in FIG. 2, indicated the average pull friction was reduced by 47% relative to control.

INCORPORATION BY REFERENCE AND EQUIVALENTS

[0078] The contents of all references (including literature references, issued patents, published patent applications, and co-pending patent applications) cited throughout this application are hereby expressly incorporated herein by reference in their entireties. Unless otherwise defined, all technical and scientific terms used herein are accorded the meaning commonly known to one of ordinary skill in the art.

[0079] Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific procedures, embodiments, claims, and examples described herein. Such equivalents are intended to be encompassed by the following claims.

[0080] It is to be understood that wherever values and ranges are provided herein, all values and ranges encompassed by these values and ranges, or a combination of these values and ranges, are meant to be encompassed within the scope of the aspects and embodiments provided herein. Moreover, all values that fall within these ranges, as well as the upper or lower limits of a range of values, are also contemplated by the present application.